Aglago, E. K., Schalkwijk, C. G., Freisling, H., Fedirko, V., Hughes, D. J., Jiao, L., Dahm, C. C., Olsen, A., Tjønneland, A., Katzke, V., Johnson, T., Schulze, M. B., Aleksandrova, K., Masala, G., Sieri, S., Simeon, V., Tumino, R., Macciotta, A., Bueno-de-Mesquita, B., Skeie, G., Gram, I. T., Sandanger, T., Jakszyn, P., Sánchez, M., Amiano, P., Colorado-Yohar, S. M., Gurrea, A. B., Perez-Cornago, A., Mayén, A., Weiderpass, E., Gunter, M. J., Heath, A. K., & Jenab, M. (2021). plasma concentrations of advanced glycation end-products and colorectal cancer risk in the EPIC study. Carcinogenesis, 42, 705–713. http://access.bl.uk/ark:/81055/vdc_100130765152.0x000045